Nektar Therapeutics (NKTR)
1.255
-0.06
(-4.92%)
USD |
NASDAQ |
Apr 19, 16:00
1.27
+0.02
(+1.20%)
After-Hours: 20:00
Nektar Therapeutics Max Drawdown (5Y): 99.30% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 99.30% |
| February 29, 2024 | 99.30% |
| January 31, 2024 | 99.30% |
| December 31, 2023 | 99.30% |
| November 30, 2023 | 99.30% |
| October 31, 2023 | 99.30% |
| September 30, 2023 | 99.30% |
| August 31, 2023 | 99.30% |
| July 31, 2023 | 99.30% |
| June 30, 2023 | 99.30% |
| May 31, 2023 | 99.30% |
| April 30, 2023 | 99.30% |
| March 31, 2023 | 99.30% |
| February 28, 2023 | 98.47% |
| January 31, 2023 | 98.13% |
| December 31, 2022 | 98.13% |
| November 30, 2022 | 97.42% |
| October 31, 2022 | 97.20% |
| September 30, 2022 | 97.20% |
| August 31, 2022 | 97.08% |
| July 31, 2022 | 97.08% |
| June 30, 2022 | 97.08% |
| May 31, 2022 | 96.87% |
| April 30, 2022 | 96.19% |
| March 31, 2022 | 96.16% |
| Date | Value |
|---|---|
| February 28, 2022 | 90.98% |
| January 31, 2022 | 90.45% |
| December 31, 2021 | 90.01% |
| November 30, 2021 | 89.75% |
| October 31, 2021 | 87.95% |
| September 30, 2021 | 87.95% |
| August 31, 2021 | 87.95% |
| July 31, 2021 | 86.66% |
| June 30, 2021 | 86.66% |
| May 31, 2021 | 86.66% |
| April 30, 2021 | 86.66% |
| March 31, 2021 | 86.66% |
| February 28, 2021 | 86.66% |
| January 31, 2021 | 86.66% |
| December 31, 2020 | 86.66% |
| November 30, 2020 | 86.66% |
| October 31, 2020 | 86.66% |
| September 30, 2020 | 86.66% |
| August 31, 2020 | 86.66% |
| July 31, 2020 | 86.66% |
| June 30, 2020 | 86.66% |
| May 31, 2020 | 86.66% |
| April 30, 2020 | 86.66% |
| March 31, 2020 | 86.66% |
| February 29, 2020 | 85.37% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
71.94%
Minimum
Apr 2019
99.30%
Maximum
Mar 2023
90.69%
Average
87.95%
Median
Aug 2021
Max Drawdown (5Y) Benchmarks
| Stereotaxis Inc | 86.04% |
| Vanda Pharmaceuticals Inc | 89.11% |
| Cara Therapeutics Inc | 98.22% |
| Marinus Pharmaceuticals Inc | 94.98% |
| DiaMedica Therapeutics Inc | 91.60% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -64.95 |
| Beta (5Y) | 0.904 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 71.47% |
| Historical Sharpe Ratio (5Y) | -0.7437 |
| Historical Sortino (5Y) | -1.072 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 43.49% |